Chunzi Huang

发表

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

R. Compans, F. Quan, Sang-Moo Kang, 2007, Journal of Virology.

Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL*

J. Bertin, C. Sehon, R. Marquis, 2013, The Journal of Biological Chemistry.

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Inﬂuenza Virus (cid:1)

R. Compans, F. Quan, Sang-Moo Kang, 2007 .

Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation

E. Waller, W. Harris, K. Darlak, 2014, Journal of Hematology & Oncology.

Incorporation of High Levels of Chimeric Human Immunodeﬁciency Virus Envelope Glycoproteins into Virus-Like Particles (cid:1)

B. Haynes, B. Hahn, Yingying Li, 2007 .

RIP3 induces apoptosis independent of pronecrotic kinase activity.

Kenta Moriwaki, Viera Kasparcova, John Bertin, 2014, Molecular cell.

RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition

J. Bertin, S. Berger, P. Gough, 2014, Proceedings of the National Academy of Sciences.

Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma.

J. Konen, J. Shupe, W. G. Wiles, 2017, JCI insight.

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice

D. Vaux, L. Gangoda, W. Alexander, 2014, eLife.

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis

Margaret A. Johns, Melissa Gilbert-Ross, A. Marcus, 2023, bioRxiv.

Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis

G. Sica, Melissa Gilbert-Ross, A. Marcus, 2020, Molecular Cancer Therapeutics.

Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles

B. Haynes, B. Hahn, Yingying Li, 2007, Journal of Virology.

Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins.

R. Compans, F. Quan, A. Vzorov, 2007, Vaccine.

Is SIRT2 required for necroptosis?

D. Green, P. Vandenabeele, J. Auwerx, 2014, Nature.

Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts

Melissa Gilbert-Ross, B. R. Achyut, A. Borovjagin, 2022, Cancer reports.

Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies.

R. Compans, F. Quan, L. Ye, 2005, Virology.

A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs.

R. Compans, F. Quan, D. Steinhauer, 2008, Vaccine.